Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
36m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
36m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
36m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
37m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Replimune Group Inc logo

Replimune Group Inc

About

Replimune Group Inc (NASDAQ:REPL) — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 10 2026
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Feb 3 2026
Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Dec 18 2025
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 7 2025
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

Financials

Revenue
$0
Market Cap
$694.44 M
EPS
-3.44

Community Chat

Ask AI

6ix6ixAIEvents